JP2023075540A - Skin texture ameliorant and gel-like skin cleanser composition - Google Patents
Skin texture ameliorant and gel-like skin cleanser composition Download PDFInfo
- Publication number
- JP2023075540A JP2023075540A JP2021188509A JP2021188509A JP2023075540A JP 2023075540 A JP2023075540 A JP 2023075540A JP 2021188509 A JP2021188509 A JP 2021188509A JP 2021188509 A JP2021188509 A JP 2021188509A JP 2023075540 A JP2023075540 A JP 2023075540A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- texture
- mass
- gel
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 230000036548 skin texture Effects 0.000 title claims abstract description 22
- 239000000284 extract Substances 0.000 claims abstract description 39
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 21
- 235000009566 rice Nutrition 0.000 claims abstract description 20
- 229940072117 fennel extract Drugs 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 7
- 239000002562 thickening agent Substances 0.000 claims abstract description 7
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 6
- 240000007594 Oryza sativa Species 0.000 claims abstract description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 4
- 239000001913 cellulose Substances 0.000 claims abstract description 4
- 229920002678 cellulose Polymers 0.000 claims abstract description 4
- 125000000542 sulfonic acid group Chemical group 0.000 claims abstract description 4
- -1 alkyl methacrylate Chemical compound 0.000 claims description 22
- 239000003795 chemical substances by application Substances 0.000 claims description 14
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 7
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- 239000004094 surface-active agent Substances 0.000 claims description 6
- 125000005250 alkyl acrylate group Chemical group 0.000 claims description 5
- 239000006260 foam Substances 0.000 abstract description 18
- 230000036620 skin dryness Effects 0.000 abstract description 8
- 229920001577 copolymer Polymers 0.000 abstract description 6
- 125000000217 alkyl group Chemical group 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 75
- 241000209094 Oryza Species 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- 238000005187 foaming Methods 0.000 description 14
- 239000004615 ingredient Substances 0.000 description 14
- 235000013399 edible fruits Nutrition 0.000 description 11
- 238000011282 treatment Methods 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 238000011156 evaluation Methods 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000002537 cosmetic Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 8
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 8
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 7
- 239000000049 pigment Substances 0.000 description 7
- 206010013786 Dry skin Diseases 0.000 description 6
- 241000212314 Foeniculum Species 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 230000037336 dry skin Effects 0.000 description 6
- 230000006872 improvement Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 239000005639 Lauric acid Substances 0.000 description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 229960005323 phenoxyethanol Drugs 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 3
- 241001474374 Blennius Species 0.000 description 3
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 150000005215 alkyl ethers Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 3
- 235000010234 sodium benzoate Nutrition 0.000 description 3
- 239000004299 sodium benzoate Substances 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 2
- KOZZOZYINRDZOU-UHFFFAOYSA-N 2-octadecoxyethyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOCCOC(=O)C(C)=C KOZZOZYINRDZOU-UHFFFAOYSA-N 0.000 description 2
- DDGPBVIAYDDWDH-UHFFFAOYSA-N 3-[dodecyl(dimethyl)azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC(O)CS([O-])(=O)=O DDGPBVIAYDDWDH-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 244000077995 Coix lacryma jobi Species 0.000 description 2
- 244000019459 Cynara cardunculus Species 0.000 description 2
- 235000019106 Cynara scolymus Nutrition 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 235000021360 Myristic acid Nutrition 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- 235000019502 Orange oil Nutrition 0.000 description 2
- 244000170916 Paeonia officinalis Species 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 2
- 244000078534 Vaccinium myrtillus Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000010306 acid treatment Methods 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229920006322 acrylamide copolymer Polymers 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 235000016520 artichoke thistle Nutrition 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000010502 orange oil Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 229940073743 steareth-20 methacrylate Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 229940104261 taurate Drugs 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- XGFQVJQXCLZRFH-ZDUSSCGKSA-N (2s)-2-(dodecanoylamino)-3-hydroxypropanoic acid Chemical class CCCCCCCCCCCC(=O)N[C@@H](CO)C(O)=O XGFQVJQXCLZRFH-ZDUSSCGKSA-N 0.000 description 1
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 1
- MTJZWYHTZFVEGI-INIZCTEOSA-N (2s)-2-(tetradecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O MTJZWYHTZFVEGI-INIZCTEOSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- YPDCDBRKWQYBPV-UHFFFAOYSA-N 2-[2-(dodecanoylamino)ethyl-(2-hydroxyethyl)amino]acetic acid;sodium Chemical compound [Na].CCCCCCCCCCCC(=O)NCCN(CCO)CC(O)=O YPDCDBRKWQYBPV-UHFFFAOYSA-N 0.000 description 1
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ILKFYYOGOCVZRU-UHFFFAOYSA-N 3-(dodecanoylamino)propanoic acid Chemical compound CCCCCCCCCCCC(=O)NCCC(O)=O ILKFYYOGOCVZRU-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 239000006087 Silane Coupling Agent Substances 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-O carboxymethyl-[3-(dodecanoylamino)propyl]-dimethylazanium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)=O MRUAUOIMASANKQ-UHFFFAOYSA-O 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 229940065856 cocoyl glycinate Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 108010006161 conchiolin Proteins 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229940012466 egg shell membrane Drugs 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940075468 lauramidopropyl betaine Drugs 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229940067631 phospholipid Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000001575 punica granatum l. bark extract Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- QKJPFZCCZMBRFB-UHFFFAOYSA-M sodium;3-aminopropanoate Chemical compound [Na+].NCCC([O-])=O QKJPFZCCZMBRFB-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 125000005480 straight-chain fatty acid group Chemical group 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Images
Abstract
Description
本発明は、肌のキメ改善剤、及び泡立ちと泡質に優れ、さらに肌のキメを整え、肌のかさつきを改善し、肌をなめらかにする使用感に優れたジェル状皮膚洗浄料に関するものである。 TECHNICAL FIELD The present invention relates to an agent for improving skin texture, and a gel-type skin cleanser which is excellent in foamability and foam quality, and has an excellent feeling of use, which improves skin texture, improves skin dryness, and makes the skin smooth. be.
肌の表面には、皮溝といわれる網目状に走っている細い溝があり、その間に、それに囲まれた大小の三角形、四角形などの扁平に高まっている部分があり、これを皮丘と呼ぶ。皮溝が細かく浅い溝からなり、皮丘の面積が小さく、全体として滑らかな表面を作っている時、キメの細かい肌と呼ぶ。それに対して、皮溝が深く、広くなって目立ち、皮丘も大きく、形状が変化しているものは、キメの粗い肌と呼ぶ。若年齢の肌ほど前者である傾向があり、加齢に伴い、あるいはストレスや外界の刺激を多く受けている人ほど、後者となっていく傾向がある。この変化を、キメが乱れると呼ぶ。 On the surface of the skin, there are thin grooves running like a mesh called sulcus cutis, and in between there are large and small triangles, quadrilaterals, and other flat raised parts, which are called ridges. . When the sulcus cutis consists of fine and shallow grooves, the area of the crest is small, and the surface is smooth as a whole, it is called fine-textured skin. On the other hand, if the sulcus cutis is deep, wide and conspicuous, and the bumps are large and the shape has changed, it is called rough skin. The younger skin tends to be the former, and the older or the more stressed or externally stimulating the person is, the more likely it is to be the latter. This change is called texture disorder.
キメの細かい肌であるほど、肌のなめらかさや透明感が高まり、美容上好ましい皮膚状態となることが知られている。また、加齢や外界の刺激によって皮膚の保湿機能が低下すると、皮膚の乾燥およびそれに伴う肌荒れ、肌のハリや弾力低下によるシワ、タルミなどの現象が惹起され、キメが乱れることが知られている。 It is known that the finer the texture of the skin, the more smooth and transparent the skin becomes, resulting in a cosmetically desirable skin condition. In addition, it is known that when the skin's moisturizing function declines due to aging and external stimuli, phenomena such as dry skin and accompanying rough skin, wrinkles and slack due to reduced firmness and elasticity of the skin are induced, and the texture is disturbed. there is
そのため、スキンケア素材を用いることで、肌質および肌のキメを整え、肌のかさつきを改善し、肌をなめらかにすることは、美容上好ましくないさまざまな皮膚状態の予防のためのケアとして極めて重要である。また、外観上の問題だけでなく、肌のキメが粗い状態を放置すると、皮膚本来の保湿機能やバリア機能の低下を引き起こすことも知られており、キメの乱れを防止・改善する方法が求められていた。 Therefore, it is extremely important to use skin care materials to improve skin quality and skin texture, improve skin dryness, and smoothen skin as care for preventing various cosmetically unfavorable skin conditions. is. In addition to the problem of appearance, it is also known that the skin's natural moisturizing function and barrier function will deteriorate if the skin texture is left untreated. had been
このようなキメの乱れを防止するために様々な化粧料や食品などの方法が提案されている。例えば、スキンケア化粧料を使用して、外的要因に起因する肌荒れを抑え肌のキメを整える場合、肌表皮の新陳代謝の促進に有効な成分、角質層の保護に有効な成分、ヒアルロン酸やコラーゲンの合成を促す成分を含む化粧料が提案されている。 In order to prevent such disturbance of texture, various methods such as cosmetics and foods have been proposed. For example, when using skin care cosmetics to suppress rough skin caused by external factors and improve skin texture, ingredients that are effective in promoting metabolism of the skin epidermis, ingredients that are effective in protecting the stratum corneum, hyaluronic acid and collagen. Cosmetics containing ingredients that promote the synthesis of
このような観点からは、新陳代謝を促進するリノレン酸を安定的に配合した抗老化剤(例えば、特許文献1を参照)、ソルビトールおよび/またはマンニトールとグリセリンおよび/またはジグリセリンを配合したキメ改善化粧料(例えば、特許文献2を参照)、皮膚浸透指数が2以上であることを特徴とする油性成分を配合したキメ改善化粧料(例えば、特許文献3を参照)、オレイン酸エチルを配合したキメを整える効果に優れた化粧料(例えば、特許文献4を参照)などが提案されている。 From this point of view, an anti-aging agent stably containing linolenic acid that promotes metabolism (see, for example, Patent Document 1), and texture-improving cosmetics containing sorbitol and/or mannitol and glycerin and/or diglycerin. (see, for example, Patent Document 2), a texture-improving cosmetic blended with an oily component characterized by having a skin permeation index of 2 or more (see, for example, Patent Document 3), and a texture-improving cosmetic blended with ethyl oleate. Cosmetics excellent in the effect of adjusting the skin (see, for example, Patent Document 4) have been proposed.
また、ウイキョウから抽出したエキスが肌に対して優れた薬効を有していることが知られており、例えばコーニファインドエンベロープ(CE)を構成するタンパク質同士を結合させる酵素であるトランスグルタミナーゼ(TG)-1の産生促進作用を見出した例(例えば、特許文献5を参照)が報告されている。このTG-1産生促進剤は、肌荒れ、乾燥肌等の皮膚の老化症状、アトピー性皮膚炎等の皮膚疾患を予防、治療又は改善に大きな効果が期待できる。 In addition, it is known that extracts extracted from fennel have excellent medicinal effects on the skin. -1 production-enhancing activity has been reported (see, for example, Patent Document 5). This TG-1 production promoter is expected to be highly effective in preventing, treating or improving skin aging symptoms such as rough skin and dry skin, and skin diseases such as atopic dermatitis.
更に、コメヌカから抽出したエキスには、γ-オリザノールや水溶性抗酸化物質が豊富に含まれ、保湿、皮脂腺賦活、フケ・カユミ防止、酸化防止効果等が報告されている(例えば、特許文献6を参照)。 Furthermore, the extract extracted from rice bran is rich in γ-oryzanol and water-soluble antioxidants, and is reported to have moisturizing, sebaceous gland activation, prevention of dandruff and itching, antioxidant effects, etc. (for example, Patent Document 6). ).
上記従来技術は、何れもキメの乱れを防止することを目的とする方法として一定の改善がなされているが、皮膚洗浄料を用いる方法に関しては、肌のバリア機能の改善、外部刺激からの肌へのダメージの低減、内側からの肌の代謝促進など複合的な要因が適切なバランスで調節される必要があり、充分な機能を発揮するまでには至っていない。 All of the above-mentioned prior arts have been improved to a certain extent as a method for the purpose of preventing texture disturbance. Multiple factors such as reduction of damage to the skin and promotion of metabolism of the skin from the inside must be adjusted in an appropriate balance, and sufficient functions have not yet been achieved.
また、ウイキョウやコメヌカから抽出されたエキスの有用性に関する上記従来技術は、いずれも一定の有用性があることを報告しているが、単独の効果に関して発見しているのみにすぎず、キメの乱れという複合的な要因によって引き起こされる肌状態に対して単独で十分な効果を有しているとはいえず、かつキメの乱れに関して報告された例はない。 In addition, the above-mentioned prior arts relating to the usefulness of extracts extracted from fennel and rice bran all report that they have a certain degree of usefulness, but they are only discoveries about single effects, and the texture is not good. It cannot be said that it has a sufficient effect alone on the skin condition caused by the complex factors of disorder, and there is no report on the disorder of texture.
したがって、本発明の目的は、上記課題を鑑みてなされたものであり、肌のキメを整え肌のかさつきを改善し。さらに泡立ちと泡質に優れ、肌をなめらかにする使用感に優れたジェル状皮膚洗浄料を提供することにある。 SUMMARY OF THE INVENTION Accordingly, an object of the present invention, which has been made in view of the above problems, is to improve the texture of the skin and improve the dryness of the skin. Furthermore, the purpose of the present invention is to provide a gel-type skin cleanser which is excellent in foamability and foam quality, and excellent in feeling of use for smoothing the skin.
本発明者らは、上記目的を達成するために鋭意研究した結果、ウイキョウエキスと、コメヌカエキスを組み合わせることによって、肌のキメを整え、肌のかさつきを改善できることを見出し、本発明を完成した。 As a result of intensive research to achieve the above object, the present inventors have found that a combination of fennel extract and rice bran extract can improve skin texture and reduce dryness, and completed the present invention.
さらに、ウイキョウエキスと、コメヌカエキスと、特定のアニオン界面活性剤と、特定の共重合体及び/又は増粘剤を含有することによって、肌のキメを整え、肌のかさつきを改善し、さらには泡立ちと泡質に優れ、肌をなめらかにする使用感に優れたジェル状皮膚洗浄料となることを見出し、本発明を完成した。 Furthermore, by containing a fennel extract, a rice bran extract, a specific anionic surfactant, and a specific copolymer and/or a thickening agent, the skin texture is adjusted, the dryness of the skin is improved, and foaming is achieved. The present inventors have found that a gel-type skin cleanser with excellent foam quality and excellent feeling of smoothing the skin can be obtained, and the present invention has been completed.
本願第一の発明は、下記(A)及び(B)を有効成分とすることを特徴とする肌のキメ改善剤である。
(A)ウイキョウエキス
(B)コメヌカエキス
The first invention of the present application is a skin texture improving agent characterized by containing the following (A) and (B) as active ingredients.
(A) Fennel extract (B) Rice bran extract
本願第二の発明は、下記(A)(B)(C)(D)を含有するジェル状皮膚洗浄剤組成物である。
(A)ウイキョウエキス
(B)コメヌカエキス
(C)カルボキシル基及び/又はスルホン酸基を含有するアニオン界面活性剤を全体質量中0.1~40質量%
(D)アクリル酸アルキル・メタクリル酸アルキル・ポリオキシエチレン共重合体及び/又はセルロース系増粘剤を全体質量中0.1~10質量%
The second invention of the present application is a gel skin cleanser composition containing the following (A), (B), (C) and (D).
(A) Fennel extract (B) Rice bran extract (C) 0.1 to 40% by mass of an anionic surfactant containing a carboxyl group and/or a sulfonic acid group in the total mass
(D) Alkyl acrylate/alkyl methacrylate/polyoxyethylene copolymer and/or cellulose-based thickener in an amount of 0.1 to 10% by mass based on the total mass
前記(A)成分が0.01質量%以上、(B)成分が0.01質量%以上でもよく、また、前記(C)成分が、脂肪酸塩、N-アシルアミノ酸系界面活性剤から選ばれる1種以上でもよい。 The component (A) may be 0.01% by mass or more, the component (B) may be 0.01% by mass or more, and the component (C) is selected from fatty acid salts and N-acyl amino acid surfactants. One or more may be used.
本発明によれば、肌のキメを整え、肌のかさつきを改善できる肌のキメ改善剤、及び肌のキメを整え、肌のかさつきを改善しつつ、さらに泡立ちと泡質に優れ、肌をなめらかにする使用感に優れたジェル状皮膚洗浄料を提供できる。 According to the present invention, there is provided a skin texture-improving agent capable of improving skin texture and skin dryness, and a skin texture-improving agent that improves skin texture and skin dryness, is excellent in foaming and foam quality, and smoothes the skin. It is possible to provide a gel-like skin cleanser with an excellent feeling of use.
以下、本発明の構成について詳述する。 The configuration of the present invention will be described in detail below.
<(A)ウイキョウエキス>
本発明の肌のキメ改善剤、及びジェル状皮膚洗浄料で用いられる(A)成分は、ウイキョウ(茴香、Foeniculum vulgare Miller)の果実より抽出されたエキスである。ウイキョウ果実エキスは、ウイキョウの果実をそのまま又は粉砕後、水、エタノール等の低級アルコール、プロピレングリコールや1,3-ブチレングリコール等の多価アルコール、ジエチレングリコールエーテル等の多価アルコールアルキルエーテルその他の極性溶媒、又はそれらの混液にて抽出して得ることが出来るが、これらに限定されるものではない。
<(A) Fennel extract>
The (A) component used in the skin texture improving agent and gel skin cleanser of the present invention is an extract extracted from the fruit of fennel (Foeniculum vulgare Miller). Fennel fruit extract is obtained by adding water, lower alcohols such as ethanol, polyhydric alcohols such as propylene glycol and 1,3-butylene glycol, polyhydric alcohol alkyl ethers such as diethylene glycol ether, and other polar solvents after crushing the fennel fruit. , or a mixture thereof, but it is not limited thereto.
これらの成分は市販されている化粧品原料として入手可能であり、一般的に糖分及びポリフェノール成分を豊富かつバランスよく含んでいることが知られている。上記のように抽出されたウイキョウエキスには、一般的には、ウイキョウ果実の純分が0.1~3.0質量%含まれている。 These ingredients are available as raw materials for cosmetics on the market, and are generally known to contain abundant and well-balanced sugar and polyphenol ingredients. The fennel extract extracted as described above generally contains 0.1 to 3.0% by mass of pure fennel fruit.
ウイキョウエキスは、それ単独でも、角層ケア(TG-1産生促進)、エイジングケア(基底膜構成成分産生促進)、美白(メラニン産生抑制)効果を有しているが、以下に詳述するコメヌカエキスと組み合わせることにより、相乗的に肌のキメを改善することができる。 Fennel extract alone has stratum corneum care (TG-1 production promotion), aging care (basement membrane component production promotion), and whitening (melanin production suppression) effects. By combining with, it is possible to synergistically improve skin texture.
本発明のジェル状皮膚洗浄剤組成物におけるウイキョウエキスの配合量は、組成物全量に対し0.01質量%以上であり、好ましくは0.01~3.0質量%、より好ましくは0.02~1.0質量%である。配合量が0.01質量%以上であれは、充分な肌のキメ及びかさつきの改善効果が得られ、また配合量が3.0質量%以下であれば、果実抽出物成分が析出したり、肌への刺激が発生する等、品質を損なうことがない。 The content of the fennel extract in the gel-like skin cleanser composition of the present invention is 0.01% by mass or more, preferably 0.01 to 3.0% by mass, more preferably 0.02%, based on the total amount of the composition. ~1.0% by mass. When the amount is 0.01% by mass or more, a sufficient effect of improving skin texture and dryness can be obtained, and when the amount is 3.0% by mass or less, the fruit extract component is precipitated. , There is no loss of quality such as irritation to the skin.
<(B)コメヌカエキス>
本発明の肌のキメ改善剤、及びジェル状皮膚洗浄料で用いられる成分(B)は、イネ科植物由来米ぬか(米糠、Oryza Sativa (Rice) Bran Extract)より抽出されたエキスである。本発明のコメヌカエキスは、イネ科植物由来米ぬかをそのまま又は粉砕後、あるいは外皮の除去や精白といった過程を経たのちに、水、エタノール等の低級アルコール、プロピレングリコールや1,3-ブチレングリコール等の多価アルコール、ジエチレングリコールエーテル等の多価アルコールアルキルエーテルその他の極性溶媒、又はそれらの混液にて抽出して得ることが出来るが、これらに限定されるものではない。
<(B) Rice bran extract>
The component (B) used in the skin texture improving agent and gel skin cleanser of the present invention is an extract extracted from rice bran derived from a gramineous plant (Oryza Sativa (Rice) Bran Extract). The rice bran extract of the present invention is prepared by adding water, lower alcohols such as ethanol, propylene glycol, 1,3-butylene glycol, etc. to the rice bran of the present invention, either as it is or after pulverization, or after undergoing processes such as removing the husk and polishing. It can be obtained by extraction with a polar alcohol, a polyhydric alcohol alkyl ether such as diethylene glycol ether, another polar solvent, or a mixture thereof, but is not limited to these.
これらの成分は市販されている化粧品原料として入手可能であり、一般的には糖類だけでなく、アミノ酸やペプチド、酸、ミネラル成分を豊富かつバランスよく含んでいることが知られている。上記のように抽出されたコメヌカエキスには、一般的には、純分が0.1~3.0質量%含まれている。 These ingredients are commercially available as raw materials for cosmetics, and are generally known to contain not only saccharides but also amino acids, peptides, acids, and mineral ingredients in an abundant and well-balanced manner. The rice bran extract extracted as described above generally contains 0.1 to 3.0% by mass of pure matter.
コメヌカエキスは、それ単独でも様々な成分を含み、肌のキメの改善作用も有していると思われるが、本発明の成分(A)ウイキョウエキスと組み合わせることによって、成分(B)の浸透促進効果により、相乗的に肌質改善作用を発揮することができる。 Rice bran extract alone contains various components and is thought to have an effect of improving skin texture. Therefore, it is possible to synergistically exhibit skin quality improving action.
本発明のジェル状皮膚洗浄剤組成物におけるコメヌカエキスの配合量は、組成物全量に対し0.01質量%以上であり、好ましくは0.01~3.0質量%、より好ましくは0.02~1.0質量%である。配合量が0.01質量%以上であれば、充分な肌のキメ及びかさつきの改善効果が得られ、また配合量が3.0質量%以下であれば、植物抽出物成分が析出したり、肌への刺激が発生する等、品質を損なうことがない。 The content of the rice bran extract in the gel-like skin cleanser composition of the present invention is 0.01 mass % or more, preferably 0.01 to 3.0 mass %, more preferably 0.02 to 0.01 mass %, based on the total amount of the composition. It is 1.0% by mass. If the blending amount is 0.01% by mass or more, a sufficient effect of improving texture and dryness of the skin can be obtained, and if the blending amount is 3.0% by mass or less, the plant extract component will precipitate. , There is no loss of quality such as irritation to the skin.
<(C)成分>
本発明で用いる(C)成分は、アニオン界面活性剤、カルボキシル基及びスルホン酸基の少なくとも一方を含有するアニオン界面活性剤であり、好ましくは脂肪酸塩、N-アシルアミノ酸系界面活性剤が挙げられる。(C)成分は、ジェル状皮膚洗浄剤組成物において、界面張力の低下による起泡目的で使用される。
<(C) Component>
Component (C) used in the present invention is an anionic surfactant, an anionic surfactant containing at least one of a carboxyl group and a sulfonic acid group, preferably a fatty acid salt and an N-acylamino acid surfactant. . The component (C) is used for the purpose of foaming by lowering the interfacial tension in the gel-like skin cleanser composition.
脂肪酸塩としては、飽和脂肪酸、不飽和脂肪酸、直鎖脂肪酸、分岐脂肪酸を問わず、カプリル酸、カプリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、アラキン酸、ベヘニン酸、オレイン酸、リノール酸、イソステアリン酸などから1種又は2種以上選択され、特にラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸が、良好な泡立ち、泡質、安定性を実現する点で好適である。 Fatty acid salts include caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, arachidic acid, behenic acid, oleic acid, linoleic acid, regardless of saturated fatty acid, unsaturated fatty acid, straight-chain fatty acid, or branched fatty acid. One or two or more selected from acids, isostearic acid, etc., and lauric acid, myristic acid, palmitic acid, and stearic acid are particularly preferred in terms of achieving good foaming, foam quality, and stability.
N-アシルアミノ酸系界面活性剤としては、N-ココイルグリシン塩、N-ラウロイルグルタミン酸塩、N-ミリストイルグルタミン酸塩、N-ラウロイル-N-メチルグリシン塩、N-ラウロイル-β-アラニン塩、N-ミリストイル-β-アラニン塩、N-ラウロイルアスパラギン酸塩、N-ラウロイルセリン塩、及びN-アシルメチルタウリン塩から選択される1種又は2種以上であることが好ましい。 N-acyl amino acid surfactants include N-cocoylglycinate, N-lauroylglutamate, N-myristoylglutamate, N-lauroyl-N-methylglycinate, N-lauroyl-β-alanine, N- It is preferably one or more selected from myristoyl-β-alanine salts, N-lauroyl aspartates, N-lauroyl serine salts, and N-acylmethyl taurate salts.
上記N-アシルアミノ酸系界面活性剤の塩部については、アルカリ金属塩、アルカノールアミン及び塩基性アミノ酸塩から選択される1種又は2種以上であることが好ましい。 The salt portion of the N-acylamino acid surfactant is preferably one or more selected from alkali metal salts, alkanolamines and basic amino acid salts.
本発明のジェル状皮膚洗浄剤組成物における(C)成分の配合量は、組成物全量に対し0.1~40質量%であり、好ましくは5~30質量%、より好ましくは15~30質量%である。配合量が0.1質量%以上であれば、泡立ち、泡質、洗浄力、使用感が良好となり、40質量%以下であれば、低温析出などの経時安定性が良好となる。 The content of component (C) in the gel-like skin cleanser composition of the present invention is 0.1 to 40% by mass, preferably 5 to 30% by mass, more preferably 15 to 30% by mass, relative to the total amount of the composition. %. When the blending amount is 0.1% by mass or more, good foaming, foam quality, detergency, and feeling during use are obtained, and when it is 40% by mass or less, the stability over time such as low-temperature deposition is good.
また、低温安定性を向上するため、さらに両性界面活性剤を含有させることが好ましい。両性界面活性剤としては、一般的に皮膚洗浄剤組成物に用いられるものであれば限定されないが、例えば、ラウリン酸アミドプロピルベタイン、ヤシ油脂肪酸アミドプロピルベタイン、ラウリルジメチルアミノ酢酸ベタイン、2-アルキル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタイン、ラウリルアミノジ酢酸ナトリウム、β-アミノプロピオン酸ナトリウム、N-ラウロイル-N’-カルボキシメチル-N’-ヒドロキシエチルエチレンジアミンナトリウムなどが挙げられる。 Moreover, in order to improve low-temperature stability, it is preferable to further contain an amphoteric surfactant. The amphoteric surfactant is not limited as long as it is commonly used in skin cleansing compositions, and examples include lauramidopropyl betaine, coconut oil fatty acid amidopropyl betaine, lauryldimethylaminoacetate betaine, and 2-alkyl surfactants. -N-carboxymethyl-N-hydroxyethylimidazolinium betaine, sodium laurylaminodiacetate, sodium β-aminopropionate, sodium N-lauroyl-N'-carboxymethyl-N'-hydroxyethylethylenediamine and the like.
<(D)成分>
本発明で用いる(D)成分は、アクリル酸アルキル・メタクリル酸アルキル・ポリオキシエチレン共重合体及びセルロース系増粘剤の少なくとも一方である。(D)成分は、ジェル状皮膚洗浄剤組成物において、増粘目的で使用される。
<(D) Component>
The component (D) used in the present invention is at least one of an alkyl acrylate/alkyl methacrylate/polyoxyethylene copolymer and a cellulose thickener. The component (D) is used for the purpose of thickening in the gel skin cleansing composition.
アクリル酸アルキル・メタクリル酸アルキル・ポリオキシエチレン共重合体としては、アクリル酸及び/又はメタクリル酸のモノマーと、アクリル酸アルキル(C1~C4)、又はメタクリル酸アルキル(C1~C4)の少なくとも1種以上のモノマーと、ポリオキシエチレン(付加数2~70)アルキル(C8~C30)エーテルとアクリル酸又はメタクリル酸のエステル化物である1種以上のモノマーとの共重合体が挙げられる。 The alkyl acrylate/alkyl methacrylate/polyoxyethylene copolymer includes acrylic acid and/or methacrylic acid monomers and at least one of alkyl acrylate (C1 to C4) and alkyl methacrylate (C1 to C4). Copolymers of the above monomers and one or more monomers that are esters of polyoxyethylene (addition number 2 to 70) alkyl (C8 to C30) ethers and acrylic acid or methacrylic acid can be mentioned.
ポリオキシエチレンアルキルエーテルとアクリル酸又はメタクリル酸のモノマーとしては、例えばポリオキシエチレン(20)ステアリルエーテルとメタクリル酸のエステル等が挙げられる。この共重合体は、通常はエマルションの状態であり、特開平11-549号公報で開示されている増粘剤がこれに該当する。市販品としては、アキュリン22(ローム・アンド・ハース・ジャパン社製)等が挙げられる。 Monomers of polyoxyethylene alkyl ether and acrylic acid or methacrylic acid include, for example, esters of polyoxyethylene (20) stearyl ether and methacrylic acid. This copolymer is usually in an emulsion state, and the thickener disclosed in JP-A-11-549 corresponds to this. Commercially available products include Aculin 22 (manufactured by Rohm and Haas Japan).
セルロース系増粘剤としては、カルボキシメチルセルロース、ヒドロキシプロピルメチルセルロース、ヒドロキシエチルセルロース等が挙げられる。 Cellulosic thickeners include carboxymethylcellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose and the like.
本発明のジェル状皮膚洗浄剤組成物にける(D)成分の配合量は、組成物全量に対し0.1~10質量%であり、好ましくは1~8質量%、より好ましくは1~5質量%である。配合量が0.1質量%以上であれば、皮膚から垂れ落ちることなく使用感が良好となり。10質量%以下であれば、ジェル状を維持でき、水とのなじみが良好で、優れた泡立ち、泡質、使用感が得られる。 The content of component (D) in the gel-like skin cleanser composition of the present invention is 0.1 to 10% by mass, preferably 1 to 8% by mass, more preferably 1 to 5%, based on the total amount of the composition. % by mass. When the blending amount is 0.1% by mass or more, the feeling of use is good without dripping from the skin. If the amount is 10% by mass or less, the gel state can be maintained, the compatibility with water is good, and excellent foaming, foam quality, and feel during use can be obtained.
本発明のジェル状皮膚洗浄剤組成物は、25℃における粘度が5,000~100,000mPa・sが好ましい。粘度が5,000mPa・s以上であれば、皮膚から垂れ落ちることなく使用感が良好となり。また粘度が100,000mPa・s以下であれば、ジェル状を維持でき、水とのなじみが良好となり、優れた泡立ち、泡質、使用感が得られる。 The gel-type skin cleansing composition of the present invention preferably has a viscosity of 5,000 to 100,000 mPa·s at 25°C. If the viscosity is 5,000 mPa·s or more, the feeling of use is good without dripping from the skin. Further, if the viscosity is 100,000 mPa·s or less, the gel state can be maintained, the compatibility with water is improved, and excellent foaming, foam quality, and feeling during use can be obtained.
<その他成分>
本発明のジェル状皮膚洗浄剤組成物は、上述した成分の他に、本発明の目的を損なわない範囲で他の成分、例えば、カチオン性界面活性剤、非イオン性界面活性剤、高分子、粉体(顔料、色素、樹脂等)、香料、保湿剤、生理活性成分、塩類、溶媒、パール化剤、中和剤、pH調整剤、昆虫忌避剤、酵素等の成分を適宜配合することができる。
<Other ingredients>
The gel-type skin cleansing composition of the present invention may contain, in addition to the above-described components, other components such as cationic surfactants, nonionic surfactants, polymers, and so on, as long as the objects of the present invention are not impaired. Components such as powders (pigments, dyes, resins, etc.), fragrances, moisturizers, physiologically active ingredients, salts, solvents, pearlizing agents, neutralizers, pH adjusters, insect repellents, enzymes, etc. can be appropriately blended. can.
また、上記粉体としては、例えば赤色201号、黄色4号、青色1号、黒色401号等の色素、黄色4号Alレーキ、黄色203号Baレーキ等のレーキ色素、ナイロンパウダー、シルクパウダー、シリコーンパウダー、セルロースパウダー、シリコーンエラストマー球状粉体、ポリエチレン末等の高分子、黄酸化鉄、赤色酸化鉄、酸化クロム、カーボンブラック、群青、紺青等の有色顔料、酸化亜鉛、酸化チタン等の白色顔料、タルク、マイカ、セリサイト、カオリン等の体質顔料、雲母チタン等のパール顔料、硫酸バリウム、炭酸カルシウム、炭酸マグネシウム、珪酸マグネシウム等の金属塩、シリカ、アルミナ等の無機粉体、ベントナイト、スメクタイト、窒化ホウ素等が挙げられる。これらの粉体の形状(球状、棒状、針状、板状、不定形状、燐片状、紡錘状など)に特に制限はない。 Examples of the powder include pigments such as Red No. 201, Yellow No. 4, Blue No. 1 and Black No. 401, lake pigments such as Yellow No. 4 Al lake and Yellow No. 203 Ba lake, nylon powder, silk powder, Silicone powder, cellulose powder, silicone elastomer spherical powder, polymers such as polyethylene powder, yellow iron oxide, red iron oxide, chromium oxide, carbon black, ultramarine blue, dark blue and other colored pigments, zinc oxide, titanium oxide and other white pigments , extender pigments such as talc, mica, sericite, and kaolin; pearl pigments such as titanium mica; metal salts such as barium sulfate, calcium carbonate, magnesium carbonate, and magnesium silicate; inorganic powders such as silica and alumina; Boron nitride etc. are mentioned. The shape of these powders (spherical, rod-like, needle-like, plate-like, amorphous, scaly, spindle-like, etc.) is not particularly limited.
上記粉体は、従来公知の表面処理、例えばフッ素化合物処理、シリコーン処理、シリコーン樹脂処理、ペンダント処理、シランカップリング剤処理、チタンカップリング剤処理
、油剤処理、N-アシル化リジン処理、ポリアクリル酸処理、金属石鹸処理、アミノ酸処理、無機化合物処理、プラズマ処理、メカノケミカル処理等によって事前に表面処理されていてもいなくても構わない。
The powder is subjected to conventionally known surface treatments such as fluorine compound treatment, silicone treatment, silicone resin treatment, pendant treatment, silane coupling agent treatment, titanium coupling agent treatment, oil treatment, N-acylated lysine treatment, polyacryl The surface may or may not have been previously surface-treated by an acid treatment, a metallic soap treatment, an amino acid treatment, an inorganic compound treatment, a plasma treatment, a mechanochemical treatment, or the like.
上記溶媒としては、例えば精製水、エタノール、軽質流動イソパラフィン、低級アルコール、エーテル類、LPG、フルオロカーボン、N-メチルピロリドン、フルオロアルコール、揮発性直鎖状シリコーン、次世代フロン等が挙げられる。 Examples of the solvent include purified water, ethanol, light liquid isoparaffin, lower alcohols, ethers, LPG, fluorocarbons, N-methylpyrrolidone, fluoroalcohols, volatile linear silicones, and next-generation freon.
上記生理活性成分としては、皮膚に塗布した場合に皮膚に何らかの生理活性を与える物質が挙げられる。例えば、抗炎症剤、老化防止剤、紫外線防御剤、ひきしめ剤、抗酸化剤、保湿剤、血行促進剤、抗菌剤、殺菌剤、乾燥剤、冷感剤、温感剤、ビタミン類、アミノ酸、創傷治癒促進剤、刺激緩和剤、鎮痛剤、細胞賦活剤、酵素成分等が挙げられる。上記生理活性成分は、天然系の植物抽出成分、海藻抽出成分、生薬成分や、化合物等が挙げられるが、これらの中でも、特に天然系の植物抽出成分、海藻抽出成分、生薬成分が安全性の点で好ましい。 Examples of the physiologically active ingredient include substances that impart some physiological activity to the skin when applied to the skin. For example, anti-inflammatory agents, anti-aging agents, UV protection agents, tightening agents, antioxidants, moisturizing agents, blood circulation promoting agents, antibacterial agents, bactericidal agents, drying agents, cooling agents, warming agents, vitamins, amino acids, Examples thereof include wound healing promoters, stimulant relievers, analgesics, cell activators, enzyme components, and the like. The physiologically active ingredients include natural plant extracts, seaweed extracts, herbal medicines, compounds, etc. Among these, natural plant extracts, seaweed extracts, and herbal medicines are particularly safe. point is preferable.
また、上記天然系の植物抽出成分、海藻抽出成分、生薬成分以外の成分としては、例えばデオキシリボ核酸、ムコ多糖類、ヒアルロン酸ナトリウム、コンドロイチン硫酸ナトリウム、コラーゲン、エラスチン、キチン、キトサン、加水分解卵殻膜などの生体高分子、アミノ酸、乳酸ナトリウム、尿素、ピロリドンカルボン酸ナトリウム、ベタイン、ホエイなどの保湿成分、スフィンゴ脂質、セラミド、コレステロール、コレステロール誘導体、リン脂質などの油性成分、ε-アミノカプロン酸、グリチルリチン酸、β-グリチルレチン酸、塩化リゾチーム、グアイアズレン、ヒドロコルチゾン等の抗炎症剤、ビタミン類(A、B2、B6、C、D、E)、パントテン酸カルシウム、ビオチン、ニコチン酸アミド、ビタミンCエステル等のビタミン類、アラントイン、ジイソプロピルアミンジクロロアセテート、4-アミノメチルシクロヘキサンカルボン酸等の活性成分、トコフェロール、カロチノイド、フラボノイド、タンニン、リグナン、サポニン等の抗酸化剤、α-ヒドロキシ酸、β-ヒドロキシ酸などの細胞賦活剤、γ-オリザノール、ビタミンE誘導体などの血行促進剤、イソプロピルメチルフェノール、トリクロサン、ヒノキチオール、塩化ベンザルコニウム、フェノキシエタノール等の殺菌剤、l-メントール、ハッカ油等の冷感剤、レチノール、レチノール誘導体等の創傷治癒剤等が挙げられる。 Ingredients other than the above natural plant extract ingredients, seaweed extract ingredients, and crude drug ingredients include, for example, deoxyribonucleic acid, mucopolysaccharides, sodium hyaluronate, sodium chondroitin sulfate, collagen, elastin, chitin, chitosan, and hydrolyzed eggshell membrane. Moisturizing ingredients such as amino acids, sodium lactate, urea, sodium pyrrolidonecarboxylate, betaine, whey, sphingolipids, ceramides, cholesterol, cholesterol derivatives, oily ingredients such as phospholipids, ε-aminocaproic acid, glycyrrhizic acid , β-glycyrrhetinic acid, lysozyme chloride, guaiazulene, anti-inflammatory agents such as hydrocortisone, vitamins (A, B2, B6, C, D, E), calcium pantothenate, biotin, nicotinamide, vitamin C ester, etc. Active ingredients such as allantoin, diisopropylamine dichloroacetate, 4-aminomethylcyclohexanecarboxylic acid, tocopherol, carotenoids, flavonoids, tannins, lignans, saponins and other antioxidants, α-hydroxy acids, β-hydroxy acids and other cells activators, blood circulation promoters such as γ-oryzanol and vitamin E derivatives, bactericides such as isopropylmethylphenol, triclosan, hinokitiol, benzalkonium chloride and phenoxyethanol, cooling agents such as l-menthol and peppermint oil, retinol, retinol Examples include wound healing agents such as derivatives.
上記pH調整剤としてはクエン酸、クエン酸ナトリウム、水酸化ナトリウム、水酸化カリウム、アルギニン、トリエタノールアミン等が挙げられる。 Examples of the pH adjuster include citric acid, sodium citrate, sodium hydroxide, potassium hydroxide, arginine, triethanolamine, and the like.
以下、実施例にて本発明を説明するが、本発明はこれら実施例により何ら限定されるものではない。実施例に記載の官能特性試験は下記の方法にて実施した。 EXAMPLES The present invention will be described below with reference to Examples, but the present invention is not limited to these Examples. Sensory property tests described in Examples were carried out by the following methods.
(キメの乱れ改善効果試験)
評価パネル10名について、顔(部位:頬)を用い、キメの乱れ改善効果試験を実施した。左右いずれかの頬に本発明のジェル状皮膚洗浄剤組成物を、もう片方の頬に純水を、一日二回適量使用し、連用試験を2週間行った。連用前後の頬の同一部位のキメの状態をマイクロスコープ(キーエンス社製、VHX-1000)で観察し、目視によってキメの深さ、大きさ、等方性の変化を観察した。キメの乱れ改善効果の評価は、「皮溝の深さ」、「皮溝の大きさ」、「凹凸性」を下記に示す標準写真と照らし合わせ、3段階の評価で採点した。さらに、平均値を算出し、その結果を表1に示す。
3段階評価基準
5点:図1のように、皮溝が細かく浅い溝からなり、皮丘の面積が小さく、全体として滑らかな表面を作っている(キメの細かい肌)
3点:図2のように、皮溝の深さや大きさがやや広くなり、皮丘の面積も大きくなり、形状が変化している(キメの粗い肌)
1点;図3のように、皮溝が大きく開いたり無くなったり、全体的にはっきりとした凹凸が認められない(キメの乱れ)
(Texture disorder improvement effect test)
An evaluation panel of 10 persons was subjected to a texture improvement effect test using the face (part: cheek). An appropriate amount of the gel-like skin cleanser composition of the present invention was applied to either the left or right cheek and pure water was applied to the other cheek twice a day, and a continuous use test was conducted for 2 weeks. The state of texture on the same site of the cheek before and after continuous use was observed with a microscope (manufactured by Keyence, VHX-1000), and changes in texture depth, size and isotropy were visually observed. The effect of improving texture disorder was evaluated by comparing "depth of sulci cutis", "size of sulci cutis", and "irregularity" with the standard photographs shown below, and scoring on a 3-grade scale. Furthermore, an average value was calculated and the results are shown in Table 1.
3-step evaluation criteria
5 points: As shown in Fig. 1, the sulcus cutis consists of fine and shallow grooves, the area of the cutaneous hill is small, and the surface as a whole is smooth (fine-textured skin).
3 points: As shown in Fig. 2, the depth and size of the sulcus cutis increased slightly, the area of the ridge increased, and the shape changed (rough skin texture).
1 point: As shown in Figure 3, the sulcus cutis is greatly opened or disappears, and no clear unevenness is observed overall (disturbance of texture).
(肌のかさつきのなさ)
専門パネル10名により、ジェル状皮膚洗浄剤組成物を1週間連用し、使用中及び使用後の肌のかさつきのなさについて官能評価を実施した。評価基準は以下の通りである。
評価基準
◎…専門パネル8名以上が使用中及び使用後肌のかさつきがないと認めた
○…専門パネル6名以上8名未満が使用中及び使用後肌のかさつきがないと認めた
△…専門パネル3名以上6名未満が使用中及び使用後肌のかさつきがないと認めた
×…専門パネル3名未満が使用中及び使用後肌のかさつきがないと認めた
(Lack of dry skin)
A panel of 10 experts continued to use the gel skin cleanser composition for one week, and carried out a sensory evaluation of the dryness of the skin during and after use. Evaluation criteria are as follows.
Evaluation criteria
◎…At least 8 members of the expert panel recognized that there was no dry skin during and after use. More than 10 people and less than 6 people recognized that there was no dry skin during or after use. ×… Less than 3 experts recognized that there was no dry skin during or after use.
(泡立ち・泡質)
専門パネル10名により、ジェル状皮膚洗浄剤組成物を使用し、泡立ち・泡質を官能試験によって5段階評価し、更にその平均点から下記基準により判定した。
5段階評価
5点:泡立ちがかなり早く、泡がかなりクリーミーで良好
4点:泡立ちがやや早く、泡がクリーミーで良好
3点:泡立ちが早く、泡がややクリーミー
2点:泡立ちがやや遅く、泡が粗く、やや柔らかい
1点:泡立ちが遅く、泡が粗く、柔らかすぎる
判定
◎:極めて良好 (10名の平均点が4点以上であった)
○:良好 (10名の平均点が3点以上4点未満であった)
△:やや悪い (10名の平均点が2点以上3点未満であった)
×:悪い (10名の平均点が2点未満であった)
(foaming/foam quality)
A panel of 10 experts evaluated the foamability and foam quality of the gel skin cleansing composition on a sensory test on a scale of 5, and the average score was used for evaluation according to the following criteria.
5-step evaluation
5 points: Foaming is fairly fast and the foam is fairly creamy and good 4 points: Foaming is slightly fast and the foam is creamy and good 3 points: Foaming is fast and the foam is slightly creamy 2 points: Foaming is slightly slow and the foam is rough Slightly soft 1 point: Foaming is slow, foam is coarse, too soft
judgement
◎: Very good (the average score of 10 people was 4 points or more)
○: Good (The average score of 10 people was 3 points or more and less than 4 points)
△: Somewhat bad (the average score of 10 people was 2 points or more and less than 3 points)
×: Bad (The average score of 10 people was less than 2 points)
(肌のなめらかさ)
専門パネル10名により、ジェル状皮膚洗浄剤組成物を1週間連用し、連用後の肌のなめらかさについて下記の5段階の評点のつけ方にて官能評価を実施した。評価基準は10名の評点の平均値を用いて、以下の通りに分類した。
評点と内容
5点…連用によって肌の手触りおよび外観が著しくなめらかになったように感じた
4点…連用によって肌の手触りおよび外観がややなめらかになったように感じた
3点…連用によって肌の手触りおよび外観がわずかになめらかになったように感じた
2点…連用によって肌の手触りおよび外観がわずかに粗く、ガサガサになったように感じた
1点…連用によって肌の手触りおよび外観が粗く、ガサガサになったように感じた
評価基準
◎:極めて良好 (10名の平均点が4点以上であった)
○:良好 (10名の平均点が3点以上4点未満であった)
△:やや悪い (10名の平均点が2点以上3点未満であった)
×:悪い (10名の平均点が2点未満であった)
(skin smoothness)
A panel of 10 experts continued to use the gel-type skin cleanser composition for one week, and sensory evaluation was carried out on the smoothness of the skin after continuous use according to the following 5-grade rating method. The evaluation criteria were classified as follows using the average score of 10 persons.
Grade and content
5 points: It felt that the texture and appearance of the skin became noticeably smoother with continued use. 4 points: The texture and appearance of the skin felt that the texture and appearance became slightly smoother with continued use. 2 points: The texture and appearance of the skin felt slightly rough and rough due to continuous use 1 point: The texture and appearance of the skin became rough and rough due to continuous use felt like
Evaluation criteria
◎: Very good (the average score of 10 people was 4 points or more)
○: Good (The average score of 10 people was 3 points or more and less than 4 points)
△: Somewhat bad (the average score of 10 people was 2 points or more and less than 3 points)
×: Bad (The average score of 10 people was less than 2 points)
実施例1~5,比較例1~3(ジェル状皮膚洗浄剤組成物)。
表1に示す組成にて、ジェル状皮膚洗浄剤組成物を調製し、上記官能特性試験を実施した。その結果を表1に併せて示す。
Examples 1 to 5 and Comparative Examples 1 to 3 (gel skin cleansing composition).
A gel-type skin cleanser composition was prepared with the composition shown in Table 1, and the sensory property test was carried out. The results are also shown in Table 1.
表1の結果から、(A)及び(B)成分を含有する実施例は、いずれもキメの乱れの改善効果と肌のかさつきのなさが良好な結果となった。さらに(C)、(D)成分を加えた実施例1~3は、比較例と対比して、泡立ちと泡質に優れ、肌をなめらかにする使用感にも優れていることが分かる。 From the results in Table 1, all of the examples containing the components (A) and (B) showed good results in the effect of improving texture disorder and the lack of dryness of the skin. Furthermore, it can be seen that Examples 1 to 3, in which the components (C) and (D) are added, are superior in foaming and foam quality, and are also excellent in the feeling of use that makes the skin smooth compared to the comparative examples.
以下、本発明に係るジェル状皮膚洗浄剤組成物の処方例を示す。いずれもキメの乱れの改善効果、肌のかさつきの無さ、泡立ちと泡質、肌をなめらかが良好であった。 Formulation examples of the gel-type skin cleansing composition according to the present invention are shown below. All of them were good in improvement effect of disordered texture, absence of skin dryness, foamability and foam quality, and smoothness of skin.
処方例1(洗顔料)
(成分名) (質量%)
1.N-ココイルグリシンカリウム 15.0
2.(アクリレーツ/メタクリル酸ステアレス-20)コポリマー 5.0
3.ラウリルヒドロキシスルタイン 2.0
4.水酸化カリウム 0.7
5.塩化ジメチルジアリルアンモニウム・アクリルアミド共重合体液 0.3
6.アスコルビン酸2-グルコシド 0.5
7.グリチルリチン酸ジカリウム 0.2
8.ウイキョウエキス 0.2
9.リンゴ果実エキス 0.2
10.ユズ果実エキス 0.2
11.ハトムギ種子抽出物 0.3
12.シャクヤク根エキス 0.05
13.加水分解コンキオリン 0.05
14.コメヌカエキス 0.1
15.クエン酸 0.05
16.クエン酸ナトリウム 0.1
17.グリセリルグルコシド 1.0
18.ヒアルロン酸Na 0.3
19.ラベンダー油 0.015
20.オレンジ油 0.2
21.ベルガモットオイル 0.015
22.フェノキシエタノール 適 量
23.安息香酸ナトリウム 適 量
24.エデト酸四ナトリウム 適 量
25.精製水 残 余
Prescription example 1 (facial cleanser)
(Component name) (% by mass)
1. Potassium N-cocoylglycine 15.0
2. (Acrylates/steareth-20 methacrylate) copolymer 5.0
3. Lauryl hydroxysultaine 2.0
4. Potassium hydroxide 0.7
5. Dimethyldiallylammonium chloride/acrylamide copolymer liquid 0.3
6. Ascorbic acid 2-glucoside 0.5
7. Dipotassium glycyrrhizinate 0.2
8. Fennel extract 0.2
9. Apple fruit extract 0.2
10. Yuzu fruit extract 0.2
11. Coix seed extract 0.3
12. Peony root extract 0.05
13. Hydrolyzed conchiolin 0.05
14. Rice bran extract 0.1
15. Citric acid 0.05
16. Sodium citrate 0.1
17. Glyceryl glucoside 1.0
18. Hyaluronic acid Na 0.3
19. Lavender oil 0.015
20. orange oil 0.2
21. Bergamot oil 0.015
22. Phenoxyethanol Appropriate amount 23. Sodium benzoate Appropriate amount 24. Tetrasodium edetate appropriate amount25. Purified water Remainder
処方例2(ボディジェル)
(成分名) (質量%)
1.N-ラウロイルサルコシンナトリウム 10.0
2.N-ココイルメチルタウリンナトリウム 3.0
3.ラウリン酸 3.0
4.ミリスチン酸 1.5
5.(アクリレーツ/メタクリル酸ステアレス-20)コポリマー 5.0
6.水酸化カリウム 1.8
7.塩化ジメチルジアリルアンモニウム・アクリルアミド共重合体液 0.15
8.トラネキサム酸 0.2
9.グリチルリチン酸ジカリウム 0.2
10.イソプロピルメチルフェノール 0.1
11.ウイキョウエキス 0.2
12.リンゴ果実エキス 0.1
13.ビルベリー果実エキス 0.1
14.アーティチョーク花エキス 0.05
15.コメヌカエキス 0.05
16.水溶性コラーゲン 1.0
17.スクワラン 2.0
18.グリセリン 3.0
19.1,3-BG 2.0
20.フェノキシエタノール 適 量
21.安息香酸ナトリウム 適 量
22.エデト酸四ナトリウム 適 量
23.香料 適 量
24.精製水 残 余
Formulation example 2 (body gel)
(Component name) (% by mass)
1. Sodium N-lauroyl sarcosinate 10.0
2. Sodium N-cocoyl methyl taurate 3.0
3. Lauric acid 3.0
4. Myristic acid 1.5
5. (Acrylates/steareth-20 methacrylate) copolymer 5.0
6. Potassium hydroxide 1.8
7. Dimethyldiallylammonium chloride/acrylamide copolymer liquid 0.15
8. Tranexamic acid 0.2
9. Dipotassium glycyrrhizinate 0.2
10. Isopropylmethylphenol 0.1
11. Fennel extract 0.2
12. Apple fruit extract 0.1
13. Bilberry fruit extract 0.1
14. Artichoke flower extract 0.05
15. Rice bran extract 0.05
16. Water-soluble collagen 1.0
17. Squalane 2.0
18. Glycerin 3.0
19.1,3-BG2.0
20. Phenoxyethanol Appropriate amount 21. Sodium benzoate Appropriate amount 22. Tetrasodium edetate appropriate amount23. Perfume Appropriate amount 24. Purified water Remainder
処方例3(シェービングジェル)
(成分名) (質量%)
1.N-ココイルグリシンカリウム 15.0
2.N-ココイルメチルタウリンナトリウム 3.0
3.ラウリン酸 2.0
4.ミリスチン酸 5.0
5.ラウリルヒドロキシスルタイン 2.0
6.ヒドロキシプロピルメチルセルロース 3.0
7.グリチルリチン酸ジカリウム 0.2
8.イソプロピルメチルフェノール 0.1
9.ウイキョウエキス 0.2
10.リンゴ果実エキス 0.1
11.ビルベリー果実エキス 0.1
12.アーティチョーク花エキス 0.05
13.コメヌカエキス 0.05
14.ハトムギ種子抽出物 0.3
15.シャクヤク根エキス 0.05
16.ザクロ果皮エキス 0.05
17.ハマメリス葉エキス 0.05
18.水溶性コラーゲン 1.0
19.ヒアルロン酸Na 0.3
20.グリセリルグルコシド 2.0
21.グリセリン 3.0
22.1,3-BG 2.0
23.クエン酸 0.05
24.クエン酸ナトリウム 0.1
25.ラベンダー油 0.015
26.オレンジ油 0.2
27.ベルガモットオイル 0.015
28.フェノキシエタノール 適 量
29.安息香酸ナトリウム 適 量
30.エデト酸四ナトリウム 適 量
31.精製水 残 余
Prescription example 3 (shaving gel)
(Component name) (% by mass)
1. Potassium N-cocoylglycine 15.0
2. Sodium N-cocoyl methyl taurate 3.0
3. Lauric acid 2.0
4. Myristic acid 5.0
5. Lauryl hydroxysultaine 2.0
6. Hydroxypropyl methylcellulose 3.0
7. Dipotassium glycyrrhizinate 0.2
8. Isopropylmethylphenol 0.1
9. Fennel extract 0.2
10. Apple fruit extract 0.1
11. Bilberry fruit extract 0.1
12. Artichoke flower extract 0.05
13. Rice bran extract 0.05
14. Coix seed extract 0.3
15. Peony root extract 0.05
16. Pomegranate peel extract 0.05
17. Hamamelis leaf extract 0.05
18. Water-soluble collagen 1.0
19. Hyaluronic acid Na 0.3
20. Glyceryl glucoside 2.0
21. Glycerin 3.0
22.1,3-BG 2.0
23. Citric acid 0.05
24. Sodium citrate 0.1
25. Lavender oil 0.015
26. orange oil 0.2
27. Bergamot oil 0.015
28. Phenoxyethanol Appropriate amount 29. Sodium benzoate Appropriate amount 30. Tetrasodium edetate appropriate amount31. Purified water Remainder
Claims (4)
(A)ウイキョウエキス
(B)コメヌカエキス A skin texture improving agent comprising the following (A) and (B) as active ingredients.
(A) Fennel extract (B) Rice bran extract
(A)ウイキョウエキス
(B)コメヌカエキス
(C)カルボキシル基及び/又はスルホン酸基を含有するアニオン界面活性剤を全体質量中0.1~40質量%
(D)アクリル酸アルキル・メタクリル酸アルキル・ポリオキシエチレン共重合体及び/又はセルロース系増粘剤を全体質量中0.1~10質量% A gel skin cleanser composition containing the following (A), (B), (C) and (D).
(A) Fennel extract (B) Rice bran extract (C) 0.1 to 40% by mass of an anionic surfactant containing a carboxyl group and/or a sulfonic acid group in the total mass
(D) Alkyl acrylate/alkyl methacrylate/polyoxyethylene copolymer and/or cellulose-based thickener in an amount of 0.1 to 10% by mass based on the total mass
4. The gel-like skin cleanser composition according to claim 2 or 3, wherein the component (C) is one or more selected from fatty acid salts and N-acyl amino acid surfactants.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021188509A JP2023075540A (en) | 2021-11-19 | 2021-11-19 | Skin texture ameliorant and gel-like skin cleanser composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021188509A JP2023075540A (en) | 2021-11-19 | 2021-11-19 | Skin texture ameliorant and gel-like skin cleanser composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2023075540A true JP2023075540A (en) | 2023-05-31 |
Family
ID=86542545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021188509A Pending JP2023075540A (en) | 2021-11-19 | 2021-11-19 | Skin texture ameliorant and gel-like skin cleanser composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2023075540A (en) |
-
2021
- 2021-11-19 JP JP2021188509A patent/JP2023075540A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11730938B2 (en) | Methods and compositions for treating skin | |
US11833242B2 (en) | Skin care formulations | |
JP6766047B2 (en) | Γ-diketone for the treatment and prevention of aging skin and wrinkles | |
JP4904811B2 (en) | External preparation for skin comprising a carbohydrate derivative of α, α-trehalose | |
CN108030764B (en) | Double-layer cleansing lotion and preparation method thereof | |
WO2021003963A1 (en) | Skincare composition for tightening skin, and preparation method therefor | |
JP2012041302A (en) | Skin cosmetic | |
WO2008115695A1 (en) | Cosmetic composition for skin tightening | |
JP2000273033A (en) | Gel comprising natural material | |
JP2015034131A (en) | Fermented fig extract, method for producing the same, and cosmetic in which fermented fig extract is blended | |
AU2013362634B2 (en) | Bee venom composition with effects of protecting and beautifying lip | |
CN113133967A (en) | Peony essence skin-moistening facial cream and preparation method thereof | |
KR20220068226A (en) | Cosmetic or dermatological composition for removing and/or cleansing makeup comprising succinic acid for preventing, reducing or eliminating skin imperfections, treating skin disorders and preventing, treating and combating hyperseborrheic conditions of the scalp | |
TW201808261A (en) | Skin care products and uses thereof | |
JP2017193506A (en) | Skin Cosmetic | |
JP2001172167A (en) | Cleanser composition | |
JP2004352627A (en) | External preparation for skin | |
JP2013136533A (en) | Anti-aging cosmetic | |
JP2023075540A (en) | Skin texture ameliorant and gel-like skin cleanser composition | |
WO2016033899A1 (en) | Dandruff removing composition for adjusting scalp oil balance | |
JP7305161B2 (en) | skin cosmetics | |
JP2023075541A (en) | Gel-like skin cleanser composition | |
JP7343885B2 (en) | skin cosmetics | |
JP2004352630A (en) | External preparation for skin | |
CN109512765A (en) | A kind of moisturizing oil of Aloe original juice and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20240325 |